Oragenics Inc. Files Proxy Materials
Ticker: OGEN · Form: DEFA14A · Filed: Apr 11, 2025 · CIK: 1174940
| Field | Detail |
|---|---|
| Company | Oragenics INC (OGEN) |
| Form Type | DEFA14A |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing
TL;DR
Oragenics filed proxy docs, no fee. Standard stuff for shareholders.
AI Summary
Oragenics Inc. filed a Definitive Additional Materials (DEFA14A) on April 11, 2025, related to its proxy statement. The filing indicates no fee was required for this submission. The company is incorporated in Florida and its fiscal year ends on December 31st.
Why It Matters
This filing is a routine regulatory submission for Oragenics Inc., providing updated proxy materials to shareholders. It's important for investors to review these documents for information regarding company governance and shareholder voting matters.
Risk Assessment
Risk Level: low — This filing is a standard DEFA14A proxy statement amendment, indicating routine corporate communication rather than a significant event.
Key Players & Entities
- ORAGENICS INC (company) — Registrant
- 0001641172-25-003811 (filing_id) — Accession Number
- 20250411 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically 'Definitive Additional Materials' for a proxy statement.
Who is the filing company?
The filing company is Oragenics Inc.
When was this filing submitted?
The filing was submitted on April 11, 2025.
Was there a filing fee associated with this submission?
No, the filing indicates 'No Fee Required'.
What is the company's fiscal year end?
Oragenics Inc.'s fiscal year ends on December 31.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 11, 2025 regarding ORAGENICS INC (OGEN).